Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 3,906 | 3,893 | 6,835 | 3,589 | 4,532 |
| Operating Income | -3,906 | -3,893 | -6,835 | -3,589 | -4,532 |
| Interest Expense | 60 | 68 | 71 | 65 | 13 |
| Other Income | 188 | 0 | 0 | -150 | -159 |
| Pre-tax Income | -3,778 | -3,961 | -6,906 | -3,804 | -4,704 |
| Net Income Continuous | -3,778 | -3,961 | -6,906 | -3,804 | -4,704 |
| Net Income | $-3,778 | $-3,961 | $-6,906 | $-3,804 | $-4,704 |
| EPS Basic Total Ops | -2.40 | -2.60 | -4.40 | -2.60 | -3.20 |
| EPS Basic Continuous Ops | -2.39 | -2.53 | -4.46 | -2.59 | -3.25 |
| EPS Diluted Total Ops | -2.40 | -2.60 | -4.40 | -2.60 | -3.20 |
| EPS Diluted Continuous Ops | -2.39 | -2.53 | -4.46 | -2.59 | -3.25 |
| EBITDA(a) | $-3,720 | $-3,705 | $-6,655 | $-3,425 | $-4,401 |